Skip to main content

Advertisement

SpringerLink
Log in

T cells in the pathogenesis of systemic lupus erythematosus: Potential roles of CD154-CD40 interactions and costimulatory molecules

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

CD154 is an activation-induced CD4 + T cell surface molecule that interacts with CD40 on antigen-presenting cells (APC) and upregulates the key costimulatory molecules, CD80 and CD86. Bidirectional intercellular signaling mediated by CD40 ligation and CD80/CD86 interactions with counter-receptors on T cells play central roles in regulating the survival and outgrowth of pathogenic autoreactive T cells and B cells in systemic lupus erythematosus (SLE). CD40 is also expressed on a variety of other cells, including endothelial cells and renal tubule epithelial cells. CD154 activation of APCs, endothelial cells, and renal tubular epithelial cells have proinflammatory or procoagulant effects that may contribute to the pathogenesis of lupus. This review will focus on the immunobiology of CD154-CD40 interactions and the costimulatory functions of CD80 and CD86. The experimental evidence suggesting roles for these molecules in the immunopathogenesis of SLE will be reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Datta S: Production of pathogenic antibodies: cognate interactions between autoimmune T and B cells. Lupus 1998, 7:591–596. This article reviews the molecular features characteristic of pathogenic anti-DNA antibodies and the nucleosomal specificity of CD4+ T cells driving anti-DNA antibody responses. The potential role of CD154 in regulating autoantibody responses in murine lupus models and human lupus is also discussed.

    Article  PubMed  CAS  Google Scholar 

  2. Tsokos G, Liossis S: Lymphocytes, cytokines, inflammation, and immune trafficking. Curr Opin Rheumatol 1998, 10:417–425. This paper summarizes recent findings that shed light on the immunopathogenesis of lupus. Key topics reviewed are genetic susceptibility factors linked to lupus and identification of T-cell receptor signaling abnormalities in patients with lupus. Additionally, the role of IL-10, T cells, B cells, and apoptosis in disease pathogenesis are discussed.

    Article  PubMed  CAS  Google Scholar 

  3. Weenink S, Gautam A: Antigen presentation by MHC class II molecules. Immunol Cell Biol 1997, 75:69–81.

    Article  PubMed  CAS  Google Scholar 

  4. Lenschow D, Walunas T, Bluestone J: CD28/B7 system of T-cell costimulation. Annu Rev Immunol 1996, 14:233–258.

    Article  PubMed  CAS  Google Scholar 

  5. Lederman S, Yellin MJ, Krichevsky A, et al.: Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J Exp Med 1992, 175:1091–1101.

    Article  PubMed  CAS  Google Scholar 

  6. Armitage RJ, Fanslow WC, Strockbine L, et al.: Molecular and biological characterization of a murine ligand for CD40. Nature 1992, 357:80–82.

    Article  PubMed  CAS  Google Scholar 

  7. Hollenbaugh D, Grosmaire LS, Kullas CD, et al.: The human T-cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: experssion of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 1992, 11:4313–4321.

    PubMed  CAS  Google Scholar 

  8. Noelle RJ, Roy M, Shepherd DM, et al.: A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 1992, 89:6550–6554.

    Article  PubMed  CAS  Google Scholar 

  9. Banchereau J, Bazan F, Blanchard D, et al.: The CD40 antigen and its ligand. Annu Rev Immunol 1994, 12:881–922.

    Article  PubMed  CAS  Google Scholar 

  10. Covey LR, Cleary AM, Yellin MJ, et al.: Isolation of cDNAs encoding T-BAM, a surface glycoprotein on CD4+ T cells mediating contact-dependent helper function for B cells: identity with the CD40-ligand. Mol Immunol 1994, 31:471–484.

    Article  PubMed  CAS  Google Scholar 

  11. Grammer A, Bergman M, Miura Y, et al.: The CD40 ligand expressed by human B cells costimulates B cell responses. J Immunol 1995, 154:4996–5010.

    PubMed  CAS  Google Scholar 

  12. Pinchuk L, Klaus S, Magaletti D, et al.: Functional CD40 ligand expressed by human blood dendritic cells is upregulated by CD40 ligation. J Immunol 1996, 157:4363–4370.

    PubMed  CAS  Google Scholar 

  13. Gauchat J, Henchoz S, Fattah D, et al.: CD40 ligand is functionally expressed on human eosinophils. Eur J Immunol 1995, 25:863–865.

    Article  PubMed  CAS  Google Scholar 

  14. Henn V, Slupsky J, Grafe M, et al.: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998, 391:591–564.

    Article  PubMed  CAS  Google Scholar 

  15. Mach F, Schnbeck U, Sukhova G, et al.: Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci, USA 1997, 94:1931–1936.

    Article  PubMed  CAS  Google Scholar 

  16. Caux C, Massacrier C, Banbervliet B, et al.: Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994, 180:1263–1272.

    Article  PubMed  CAS  Google Scholar 

  17. Kiener P, Moran-Davis P, Rankin B, et al.: Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 1995, 155:4917–4925.

    PubMed  CAS  Google Scholar 

  18. Karmann K, Hughes CCW, Schechner J, et al.: CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 1995, 92:4342–4346.

    Article  PubMed  CAS  Google Scholar 

  19. Yellin MJ, Brett J, Baum D, et al.: Functional interactions of T cells with endothelial cells: the role of CD40L-CD40 mediated signals. J Exp Med 1995, 182:1857–1864.

    Article  PubMed  CAS  Google Scholar 

  20. Yellin MJ, Winikoff S, Fortune SM, et al.: Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) upregulation, IL-6 production and proliferation. J Leuk Biol 1995, 58:209–216.

    CAS  Google Scholar 

  21. Young L, Eliopoulos A, Gallagher N, et al.: CD40 and epithelial cells: across the great divide. Immunol Today 1998, 19:502–506.

    Article  PubMed  CAS  Google Scholar 

  22. Peguet-Navarro J, Dalbiez-Gauthier C, Moulon C, et al.:CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation. J Immunol 1997, 158:144–152.

    PubMed  CAS  Google Scholar 

  23. Van den Eertwegh A, Noelle R, Roy M, et al.: In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B-cell interactions. J Exp Med 1993, 178:1555–1565.

    Article  PubMed  Google Scholar 

  24. van Kooten C, Gaillard C, Galizzi JP, et al.: B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur J Immunol 1994, 24:787–792.

    Article  PubMed  Google Scholar 

  25. Yellin MJ, Sippel K, Inghirami G, et al.: CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L: potential role in regulating helper effector function. J Immunol 1994, 152:598–608.

    PubMed  CAS  Google Scholar 

  26. Ranheim EA, Kipps TJ: Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 1993, 177:925–935.

    Article  PubMed  CAS  Google Scholar 

  27. Yellin MJ, Sinning J, Covey LR, et al.: T lymphocyte T cell-B cellactivating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. J Immunol 1994, 153:666–74.

    PubMed  CAS  Google Scholar 

  28. Yang Y, Wilson J: CD40 ligand-dependent T-cell activation: requirement of B7-CD28 signaling through CD40. Science 1996, 273:1862–1864.

    Article  PubMed  CAS  Google Scholar 

  29. Grewal I, Xu J, Flavell R: Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 1995, 378:617–620.

    Article  PubMed  CAS  Google Scholar 

  30. Clark EA, Ledbetter JA: How B and T cells talk to each other. Science 1994, 367:425–428.

    CAS  Google Scholar 

  31. Lederman S, Yellin MJ, Inghirami G, et al.: Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J Immunol 1992, 149:3817–3826.

    PubMed  CAS  Google Scholar 

  32. Cleary AM, Fortune SM, Yellin MJ, et al.: Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells. J Immunol 1995, 155:3329–3337.

    PubMed  CAS  Google Scholar 

  33. Lederman S, Yellin MJ, Cleary AM, et al.: T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J Immunol 1994, 152:2163–2171.

    PubMed  CAS  Google Scholar 

  34. Stout R, Suttles J: The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today 1996, 17:487–492.

    Article  PubMed  CAS  Google Scholar 

  35. Malik N, Greenfield B, Wahl A, et al.: Activation of human monocytes through CD40 induces matrix metalloproteinases. J Immunol 1996, 156:3952–3960.

    PubMed  CAS  Google Scholar 

  36. Stout R, Suttles J, Xu J, et al.: Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol 1996, 156:8–11.

    PubMed  CAS  Google Scholar 

  37. Kornbluth R, Kee K, Richman D: CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines. Proc Natl Acad Sci U S A 1998, 95.

  38. Sempowski G, Chess P, Phipps R: CD40 is a functional activation antigen and B7-independent T cell costimulatory molecule on normal human lung fibroblasts. J Immunol 1997, 158:4670–4677.

    PubMed  CAS  Google Scholar 

  39. Pradier OF, Willems D, Abramowicz et al.: CD40 engagement induces monocyte procoagulant activity through an interleukin-10 resistant pathway. Eur J Immunol 1996, 26:3048–3054.

    Article  PubMed  CAS  Google Scholar 

  40. Miller D, Yaron R, Yellin M: CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression. J Leuk Biol 1997, 63:373–379.

    Google Scholar 

  41. Zhang Y, Cao H, Graf B, et al.: CD40 engagement upregulates cyclooxygenase-2 expression and prostaglandin E2 production in human lung fibroblasts. J Immunol 1998, 160:1053–1057.

    PubMed  CAS  Google Scholar 

  42. Mohan C, Shi Y, Laman JD, et al.: Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 1995, 154:1470–1480.

    PubMed  CAS  Google Scholar 

  43. Blossom S, Chu E, Weigle W, et al.: CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus. J Immunol 1997, 159:4580–4586.

    PubMed  CAS  Google Scholar 

  44. Early G, Zhao W, Burns C: Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black New Zealand white mice. Response correlates with the absence of an anti-antibody response. J Immunol 1996, 157:3159–3164.

    PubMed  CAS  Google Scholar 

  45. Ma J, Xu J, Madaio M, et al.: Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses. J Immunol 1996, 157:417–426.

    PubMed  CAS  Google Scholar 

  46. Peng S, McNiff J, Madaio M, et al.: alpha beta T cell regulation and CD40 ligand dependence in murine systemic autoimmunity. J Immunol 1997, 158:2464–2470.

    PubMed  CAS  Google Scholar 

  47. Russell J, Mooney T, Cohen P, et al.: Anti-CD40L accelerates renal disease and adenopathy in MRL-lpr mice in parallel with decreased thymocyte apoptosis. J Immunol 1998, 161:729–739.

    PubMed  CAS  Google Scholar 

  48. Kalled SL, Cutler A, et al.: Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function. J Immunol 1998, 160:2158–2165. This paper demonstrates that blocking CD154-CD40 interactions in lupus-prone SNF1 mice with established renal disease prevents disease progression and markedly prolongs survival. Treated animals demonstrated reduced proteinuria, and this was associated with decreased renal inflammation and fibrosis.

    PubMed  CAS  Google Scholar 

  49. Finck B, Linsley P, Wofsy D: Treatment of murine lupus with CTLA4Ig. Science 1994, 265:1225–1227.

    Article  PubMed  CAS  Google Scholar 

  50. Nakajima A, Azuma M, Kodera S, et al.: Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Eur J Immunol 1995, 25:3060–3069.

    Article  PubMed  CAS  Google Scholar 

  51. Daikh D, Finck B, Linsley P, et al.: Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/ CD28 and CD40/gp39 costimulation pathways. J Immunol 1997, 159:3104–3108. The authors demonstrate that simultaneous blockade of the B7-CD28 and CD154-CD40 pathways inhibits the development of renal disease and autoantibody production in NZB/NZW F1 mice. A 2-week course of treatment with anti-CD154 mAb and CTLA4-Ig at the time of disease onset resulted in prolonged survival and decreased manifestations of disease.

    PubMed  CAS  Google Scholar 

  52. Koshy M, Berger D, Crow M: Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 1996, 98:826–837.

    Article  PubMed  CAS  Google Scholar 

  53. Desai-Mehta A, Lu L, Ramsey-Goldman R, et al.: Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996, 97:2063–2073.

    Article  PubMed  CAS  Google Scholar 

  54. Devi B, Van Noordin S, Krausz T, et al.: Peripheral blood lymphocytes in SLE—hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells. J Autoimmun 1998, 11:471–475.

    Article  PubMed  CAS  Google Scholar 

  55. Fernandez-Gutierrez B, de Miguel S, Morado C, et al.: Defective early T and T-dependent B-cell activation in systemic lupus erythematosus. Lupus 1998, 7:14–22.

    Article  Google Scholar 

  56. Liossis S, Ding X, Dennis G, et al.: Altered pattern of TCR/ CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J Clin Invest 1998, 101:1448–1457. This article documents that patients with lupus have abnormal tyrosine phosphorylation patterns following TCR/CD3 ligation. Further investigation of this phenomenon demonstrated that many patients with lupus lacked the zeta chain, a key component of the TCR/CD3 complex. These findings define a molecular basis for abnormal TCR/CD3 signaling in patients with lupus.

    Article  PubMed  CAS  Google Scholar 

  57. Folzenlogen D, Hofer M, Leung D, et al.: Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin Immunol Immunopathol 1997, 83:199–204.

    Article  PubMed  CAS  Google Scholar 

  58. Liu M, Li J, Weng T, et al.: Differential expression and modulation of costimulatory molecules CD80 and CD86 on monocytes from patients with systemic lupus erythematosus. Scand J Immunol 1999, 49:82–87.

    Article  PubMed  CAS  Google Scholar 

  59. Garcia-Cozar F, Molina I, Cuadrado M, et al.: Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients. Clin Exp Immunol 1996, 104:72–79.

    Article  PubMed  CAS  Google Scholar 

  60. Via C, Tsokos G, Bermas B, et al.: T cell-antigen-presenting cell interactions in human systemic lupus erythematosus. Evidence for heterogeneous expression of multiple defects. J Immunol 1993, 151:3914–3922.

    PubMed  CAS  Google Scholar 

  61. Tsokos G, Kovacs B, Sfikakis P, et al.: Defective antigenpresenting cell function in patients with systemic lupus erythematosus. Arthritis Rheum 1996, 39:600–609.

    Article  PubMed  CAS  Google Scholar 

  62. Roth R, Gee R, Mamula M: B lymphocytes as autoantigenpresenting cells in the amplification of autoimmunity. Ann N Y Acad Sci 1997, 815:88–104.

    Article  PubMed  CAS  Google Scholar 

  63. Rathmell J, Fournier S, Weintraub B, et al.: Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells. J Exp Med 1998, 188:651–659.

    Article  PubMed  CAS  Google Scholar 

  64. Alexopoulos E, Seron D, Hartley R, et al.: Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int 1990, 37:100–109.

    Article  PubMed  CAS  Google Scholar 

  65. Yellin M, D’Agati V, Parkinson G, et al.: Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides. Arthritis Rheum 1997, 40:124–134. This paper demonstrates that renal CD40 expression is upregulated on many cells in Class III and Class IV lupus nephritis, including renal tubule epithelial cells, endothelial cells, mesangial cells, and parietal epithelial cells. This is associated with infiltrating interstitial CD154+ T cells. These findings suggest that CD154-CD40 interactions directly contribute to renal inflammation in lupus nephritis.

    Article  PubMed  CAS  Google Scholar 

  66. Massengill S, Goodenow M, Sleasman J: SLE nephritis is associated with an oligoclonal expansion of intrarenal T cells. Am J Kidney Dis 1998, 31:418–426. This paper demonstrates the expansion of oligoclonal T cells bearing particular Vb TCR genes in renal biopsy specimens taken from four children with recent-onset lupus nephritis. This finding suggests that T cells respond to local antigenic stimuli and supports the concept that renal interstitial cellular immune responses contribute to the pathogenesis of lupus nephritis.

    Article  PubMed  CAS  Google Scholar 

  67. Deckers J, De Haij S, van der Woude F, et al.: IL-4 and IL-13 augment cytokine- and CD40-induced RANTES production by human renal tubular epithelial cells in vitro. J Am Soc Nephrol 1998, 9:1187–1193.

    PubMed  CAS  Google Scholar 

  68. van Kooten C, Gerritsma J, Paape M, et al.: Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney. Kidney Int 1997, 51:711–721.

    Article  PubMed  Google Scholar 

  69. Mach F, Schonbeck U, Sukhova G, et al.: Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998, 394:200–203. This paper demonstrates that blocking CD154-CD40 interactions markedly attenuates the development of atherosclerotic lesions in LDL-R knock-out mice fed an atherogenic diet. Disrupting CD154-mediated signals in these mice resulted in reduced size of aortic atheromas, as well as reduction in lesion lipid content, inflammatory cell infiltrate, and CD106 (VCAM-1) expression.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Columbia University, New York, NY, USA

    Michael J. Yellin MD & Ulrich Thienel MD

Authors
  1. Michael J. Yellin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulrich Thienel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yellin, M.J., Thienel, U. T cells in the pathogenesis of systemic lupus erythematosus: Potential roles of CD154-CD40 interactions and costimulatory molecules. Curr Rheumatol Rep 2, 24–31 (2000). https://doi.org/10.1007/s11926-996-0065-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-996-0065-8

Keywords

Search

Navigation